Targeted treatment for fragile X syndrome: results of a randomized controlled phase II trial of arbaclofen

被引：0
|
作者：
Hagerman, Randi [1 ,2 ]
Rathmell, Barbara [3 ]
Wang, Lulu [1 ,2 ]
Carpenter, Randy [3 ]
Wang, Paul [3 ]
Berry-Kravis, Elizabeth [4 ]
机构：
[1] UC Davis Med Ctr, MIND Inst, Sacramento, CA USA
[2] UC Davis Med Ctr, Dept Pediat, Sacramento, CA USA
[3] Seaside Therapeut, Boston, MA USA
[4] Rush Univ, Med Ctr, Dept Neurol, Chicago, IL 60612 USA
来源：
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH | 2010年 / 54卷
关键词：
fragile X syndrome; targeted treatments; GABA; arbaclofen;
D O I：
暂无
中图分类号：
G76 [特殊教育];
学科分类号：
040109 ;
摘要：
引用
收藏
页码：884 / 884
页数：1
相关论文
共 50 条
  • [31] Advances in treatment of fragile X syndrome
    Lisik, Malgorzata
    Sieron, Aleksander
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2010, 44 (05) : 504 - 510
  • [32] Disease-Targeted Treatment Translation in Fragile X Syndrome as a Model for Neurodevelopmental Disorders
    Berry-Kravis, Elizabeth
    JOURNAL OF CHILD NEUROLOGY, 2022, 37 (10-11) : 797 - 812
  • [33] Medical treatment of fragile X syndrome
    Artigas-Pallarés, J
    Brun-Gasca, C
    REVISTA DE NEUROLOGIA, 2001, 33 : S41 - S50
  • [34] A feasibility trial of Cogmed working memory training in fragile X syndrome
    Au, Jacky
    Berkowitz-Sutherland, Laura
    Schneider, Andrea
    Schweitzer, Julie B.
    Hessl, David
    Hagerman, Randi
    JOURNAL OF PEDIATRIC GENETICS, 2014, 3 (03) : 147 - 156
  • [35] A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)
    Elizabeth Berry-Kravis
    Randi Hagerman
    Dejan Budimirovic
    Craig Erickson
    Helen Heussler
    Nicole Tartaglia
    Jonathan Cohen
    Flora Tassone
    Thomas Dobbins
    Elizabeth Merikle
    Terri Sebree
    Nancy Tich
    Joseph M. Palumbo
    Stephen O’Quinn
    Journal of Neurodevelopmental Disorders, 2022, 14
  • [36] A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome
    Hess, Laura Greiss
    Fitzpatrick, Sarah E.
    Nguyen, Danh V.
    Chen, Yanjun
    Gaul, Kimberly N.
    Schneider, Andrea
    Chitwood, Kerrie Lemons
    Eldeeb, Marwa Abd Al Azaim
    Polussa, Jonathan
    Hessl, David
    Rivera, Susan
    Hagerman, Randi J.
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2016, 37 (08) : 619 - 628
  • [37] Review of Salient Investigational Drugs for the Treatment of Fragile X Syndrome
    Munshi, Kaizad
    Pawlowski, Katherine
    Gonzalez-Heydrich, Joseph
    Picker, Jonathan D.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2017, 27 (10) : 850 - 863
  • [38] A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)
    Berry-Kravis, Elizabeth
    Hagerman, Randi
    Budimirovic, Dejan
    Erickson, Craig
    Heussler, Helen
    Tartaglia, Nicole
    Cohen, Jonathan
    Tassone, Flora
    Dobbins, Thomas
    Merikle, Elizabeth
    Sebree, Terri
    Tich, Nancy
    Palumbo, Joseph M.
    O'Quinn, Stephen
    JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2022, 14 (01)
  • [39] Targeted GABA A Modulation in the Mouse Model of Fragile X Syndrome
    Erickson, Craig
    Fitzpatrick, Sarah
    Davenport, Matthew
    Pedapati, Ernest
    Sweeney, John
    Schaefer, Tori
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S581 - S582
  • [40] Risperidone Treatment for Irritability in Fragile X Syndrome
    Dominick, Kelli C.
    Wink, Logan K.
    Pedapati, Ernest V.
    Shaffer, Rebecca
    Sweeney, John A.
    Erickson, Craig A.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (04) : 274 - 278
12345